The Small Business Personal Protective Equipment (PPE) Tax Credit Act HR 7216 has been introduced by a bipartisan coalition to provide small businesses with a $25,000 tax credit for purchasing the PPE required to reopen. The bill—sponsored…

While the United States struggles to contain the COVID-19 pandemic, dentistry continues its recovery, according to a new poll by the American Dental Association Health Policy Institute. Taken during the week of June 15, the poll shows that…

The United States Food and Drug Administration recently released a statement advising against the use of hand sanitizer manufactured by Mexico-based Eskbiochem SA de CV.

Clinical trials on an inhaled type of the antiviral treatment remdesivir will start on patients with COVID-19 beginning in August. Phase 1 trials on healthy volunteers will begin the week of June 22. Made by Gilead Sciences Inc, remdesivir…

European researchers suggest that blood type may impact the risk of acquiring COVID-19 as well as the severity of symptoms once infected. Published in the New England Journal of Medicine, the study examined the genes of more than 4,000…

A review of the literature published in Function suggests that mouthrinses may be able to penetrate the lipid envelope that encases the novel coronavirus and its spike glycoproteins that cause the infection. The review notes that…

The Organization for Safety, Asepsis, and Prevention (OSAP) has created a new, living document to help oral health professionals implement the guidelines for the safe reopening of dental practices provided by the United States Centers for…

The United States Centers for Disease Control and Prevention (CDC) updated its Guidance for Dental Settings on June 17. The changes encompass waiting periods prior to disinfection and timeline of when to report COVID-19 symptoms. The…

With 90% of dental practices now open for elective procedures, according to data from the American Dental Association Health Policy Institute, most oral health professionals are back to work. However, anxiety remains about the safety of…

New evidence out of Oxford University shows the use of an inexpensive steroid, dexamethasone, can decrease the number of deaths in those with COVID-19. The United Kingdom-based study found that the drug reduced deaths among one-third of…